Blood test may replace scalpel for heart tumor diagnosis

NCT ID NCT07235865

Recruiting now Diagnosis Sponsor: Niguarda Hospital Source: ClinicalTrials.gov ↗

First seen Nov 19, 2025 · Last updated May 16, 2026 · Updated 29 times

Summary

This study explores whether a blood test (liquid biopsy) can accurately diagnose heart masses, distinguishing benign from malignant tumors without invasive tissue sampling. Researchers will collect blood from 26 participants aged 12 and older with known or suspected cardiac masses, and compare results with standard tissue biopsies. If successful, this approach could reduce the need for risky surgical biopsies and enable earlier, safer diagnosis.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CARDIAC MASSES are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••
Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Niguarda Hospital
RECRUITING

Milan, Italia, 20262, Italy

Contact Phone: •••-•••-•••• Email: •••••@•••••

Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.

CARDIAC MASSES